Cargando…
Post-treatment changes in hematological parameters predict response to nivolumab monotherapy in non-small cell lung cancer patients
BACKGROUND: The absolute neutrophil count (ANC), absolute lymphocyte count (ALC), absolute monocyte count (AMC) and neutrophil to lymphocyte ratio (NLR) are known markers of inflammation. We evaluated whether ANC, ALC, AMC and NLR, both before and after treatment with nivolumab, are indicative marke...
Autores principales: | Khunger, Monica, Patil, Pradnya Dinkar, Khunger, Arjun, Li, Manshi, Hu, Bo, Rakshit, Sagar, Basu, Arnab, Pennell, Nathan, Stevenson, James P., Elson, Paul, Panchabhai, Tanmay S., Velcheti, Vamsidhar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6201866/ https://www.ncbi.nlm.nih.gov/pubmed/30359383 http://dx.doi.org/10.1371/journal.pone.0197743 |
Ejemplares similares
-
A Case of a Patient with Idiopathic Pulmonary Fibrosis with Lung Squamous Cell Carcinoma Treated with Nivolumab
por: Khunger, Monica, et al.
Publicado: (2017) -
Dabrafenib in combination with trametinib in the treatment of patients with BRAF V600-positive advanced or metastatic non-small cell lung cancer: clinical evidence and experience
por: Khunger, Arjun, et al.
Publicado: (2018) -
Novel pharmacologic approach to enhance the epigenetic and immune priming effect of decitabine in patients with advanced non-small cell lung cancer
por: Velcheti, Vamsidhar, et al.
Publicado: (2015) -
Managing human bites
por: Patil, Pradnya D, et al.
Publicado: (2009) -
Complications of Tattoos and Tattoo Removal: Stop and Think Before you ink
por: Khunger, Niti, et al.
Publicado: (2015)